The relentless progression of neurodegenerative diseases, such as Huntington's disease, necessitates a shift in therapeutic strategies, moving beyond symptomatic control towards disease-modifying therapies. Recent https://dawudswap632905.activoblog.com/50624242/emerging-therapeutic-targets-in-brain-disease